Neuraxis, INC (NRXS) SEC Filings — 2024
21 SEC filings for Neuraxis, INC (NRXS) in 2024.
Filings
- Rosalind Advisors Discloses 9.9% Stake in Neuraxis, Inc. — SC 13D · Dec 2, 2024
- Neuraxis Appoints New Directors, Updates Executive Contracts — 8-K · Nov 25, 2024
- Neuraxis, Inc. Files 8-K: Rights, Bylaws, and Financials Updated — 8-K · Nov 21, 2024
- Neuraxis, Inc. Files 8-K on Material Agreement & Equity Sales — 8-K · Nov 15, 2024
- Neuraxis, Inc. Files Q3 2024 10-Q Report — 10-Q · Nov 12, 2024
- Neuraxis, Inc. Files 8-K on Material Agreement & Equity Sales — 8-K · Oct 18, 2024
- Neuraxis, INC SC 13G/A Filing — SC 13G/A · Oct 8, 2024
- Neuraxis Reports Unregistered Equity Sales — 8-K · Sep 13, 2024
- Neuraxis, Inc. Files 8-K on Security Holder Votes and Exhibits — 8-K · Aug 21, 2024
- Neuraxis, Inc. Files Q2 2024 10-Q — 10-Q · Aug 9, 2024
- Neuraxis Appoints New Directors, Adjusts Executive Pay — 8-K · Jul 5, 2024
- Neuraxis Inc. Files Definitive Proxy Statement — DEF 14A · Jul 1, 2024
- Neuraxis, Inc. Files 8-K for Material Definitive Agreement — 8-K · May 28, 2024
- Neuraxis, Inc. Files Q1 2024 10-Q Report — 10-Q · May 20, 2024
- Neuraxis, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 16, 2024
- Neuraxis Restates Financials Due to Reporting Errors — 8-K · Apr 9, 2024
- Neuraxis, Inc. Files 8-K for Material Definitive Agreement — 8-K · Mar 28, 2024
- Neuraxis Appoints New CMO, Adds Directors — 8-K · Mar 11, 2024
- Neuraxis Enters Material Agreement, Incurs New Financial Obligation — 8-K · Feb 15, 2024
- Neuraxis, INC SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Neuraxis, Inc. Changes Principal Executive Office Address — 8-K · Jan 31, 2024